Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Carla Nester

Showing results (1-10 of 14) with videos related to

Pageof 2
Sort By:
Clinical Journal of the American Society of Nephrology : CJASN|February 6, 2026
Practical Considerations for Infection Prevention With the Clinical Use of Complement InhibitorsAnuja Java, Aruna Subramanian, Carla Nester
Pediatric Nephrology (Berlin, Germany)|February 20, 2026
A nephritic puzzle: C3-dominant glomerulonephritis as a sentinel of hidden autoinflammatory diseaseRyan C Ward, Polly Ferguson, Prerna Rastogi, et al.
Clinical Journal of the American Society of Nephrology : CJASN|May 28, 2011
Pre-emptive eculizumab and plasmapheresis for renal transplant in atypical hemolytic uremic syndromeCarla Nester, Zoe Stewart, David Myers, et al.
Pediatric Research|December 15, 2024
Extrarenal manifestations of atypical hemolytic uremic syndrome: a systematic review and meta-analysisKush Doshi, Abdel Yusuf, Christoph Licht, et al.
Pediatric Nephrology (Berlin, Germany)|December 9, 2025
Incidence and severity of extrarenal manifestations and outcomes in pediatric hemolytic uremic syndrome: a retrospective cohort studyRupesh Raina, Keval Yerigeri, Kush Doshi, et al.
Journal of the American Society of Nephrology : JASN|November 1, 2018
Genetic Analysis of 400 Patients Refines Understanding and Implicates a New Gene in Atypical Hemolytic Uremic SyndromeFengxiao Bu, Yuzhou Zhang, Kai Wang, et al.
Journal of the American Society of Nephrology : JASN|August 19, 2015
High-Throughput Genetic Testing for Thrombotic Microangiopathies and C3 GlomerulopathiesFengxiao Bu, Nicolo Ghiringhelli Borsa, Michael B Jones, et al.
American Journal of Nephrology|November 21, 2022
Baseline Clinical Characteristics and Complement Biomarkers of Patients with C3 Glomerulopathy Enrolled in Two Phase 2 Studies Investigating the Factor D Inhibitor DanicopanSteven D Podos, Howard Trachtman, Gerald B Appel, et al.
Kidney International Reports|December 18, 2023
Efficacy and Safety of Iptacopan in Patients With C3 GlomerulopathyEdwin Wong, Carla Nester, Teresa Cavero, et al.
Pediatric Nephrology (Berlin, Germany)|April 11, 2015
An international consensus approach to the management of atypical hemolytic uremic syndrome in childrenChantal Loirat, Fadi Fakhouri, Gema Ariceta, et al.
Pageof 2

Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
Clinical Journal of the American Society of Nephrology : CJASN|February 6, 2026
Practical Considerations for Infection Prevention With the Clinical Use of Complement InhibitorsAnuja Java, Aruna Subramanian, Carla Nester
Pediatric Nephrology (Berlin, Germany)|February 20, 2026
A nephritic puzzle: C3-dominant glomerulonephritis as a sentinel of hidden autoinflammatory diseaseRyan C Ward, Polly Ferguson, Prerna Rastogi, et al.
Clinical Journal of the American Society of Nephrology : CJASN|May 28, 2011
Pre-emptive eculizumab and plasmapheresis for renal transplant in atypical hemolytic uremic syndromeCarla Nester, Zoe Stewart, David Myers, et al.
Pediatric Research|December 15, 2024
Extrarenal manifestations of atypical hemolytic uremic syndrome: a systematic review and meta-analysisKush Doshi, Abdel Yusuf, Christoph Licht, et al.
Pediatric Nephrology (Berlin, Germany)|December 9, 2025
Incidence and severity of extrarenal manifestations and outcomes in pediatric hemolytic uremic syndrome: a retrospective cohort studyRupesh Raina, Keval Yerigeri, Kush Doshi, et al.
Journal of the American Society of Nephrology : JASN|November 1, 2018
Genetic Analysis of 400 Patients Refines Understanding and Implicates a New Gene in Atypical Hemolytic Uremic SyndromeFengxiao Bu, Yuzhou Zhang, Kai Wang, et al.
Journal of the American Society of Nephrology : JASN|August 19, 2015
High-Throughput Genetic Testing for Thrombotic Microangiopathies and C3 GlomerulopathiesFengxiao Bu, Nicolo Ghiringhelli Borsa, Michael B Jones, et al.
American Journal of Nephrology|November 21, 2022
Baseline Clinical Characteristics and Complement Biomarkers of Patients with C3 Glomerulopathy Enrolled in Two Phase 2 Studies Investigating the Factor D Inhibitor DanicopanSteven D Podos, Howard Trachtman, Gerald B Appel, et al.
Kidney International Reports|December 18, 2023
Efficacy and Safety of Iptacopan in Patients With C3 GlomerulopathyEdwin Wong, Carla Nester, Teresa Cavero, et al.
Pediatric Nephrology (Berlin, Germany)|April 11, 2015
An international consensus approach to the management of atypical hemolytic uremic syndrome in childrenChantal Loirat, Fadi Fakhouri, Gema Ariceta, et al.
Pageof 2